FDA Inspection 886230 — Bloodworks

Bloodworks — FEI 3001617760

The FDA completed an inspection of Bloodworks on Jul 3, 2014 in Renton, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 3, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Renton, WA (United States)

Citations

IDCFRDescription
23821 CFR 640.11(a)General requirements - storage
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.